Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)

Conditions:   Autism Spectrum Disorder;   Autism;   ASD;   Autistic Thinking;   Autistic Behavior;   Finch;   FMT;   Fecal Microbiota Transplant;   CP101;   SPROUT;   Fecal Transplant Interventions:   Drug: CP101;   Drug: Placebo Sponsor:   Finch Research and Development LLC. Not yet recruiting

Source: ClinicalTrials.gov - February 4, 2019 Category: Research Source Type: clinical trials